InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
0
T+90 hit rate
31%
T+90 mean return
-8.1%
Across 13 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by SULIMAN SHEHNAAZ, Director. Director active across 3 companies, notably Alector, Inc.. In total, 17 disclosures have been logged. History available since 7 May 2021. The latest transaction was disclosed on 15 May 2025 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations17 total
5,740 shares0Common StockSEC:0000950170-25-074669:0
5,345 shares0Common StockSEC:0000950170-24-075483:0
8,649 shares0Class A Common StockSEC:0001610717-24-000327:0
1,865 shares0Class A Common StockSEC:0001610717-23-000176:0
3,860 shares0Common StockSEC:0001209191-23-035689:0
3,300 shares0Common StockSEC:0001209191-22-039562:0
2,120 shares0Class A Common StockSEC:0001567619-22-013120:0
75,000 shares@ US$17.230.48% mcap39.5% of flowCommon StockSEC:0001209191-21-069643:0
75,000 shares@ US$17.230.48% mcap79.1% of flowCommon StockSEC:0001209191-21-069643
19,813 shares@ US$17.230.13% mcap10.5% of flowCommon StockSEC:0001209191-21-069130:0
19,813 shares@ US$17.230.13% mcap20.9% of flowCommon StockSEC:0001209191-21-069130
2,145 shares0Common StockSEC:0001209191-21-043535
2,145 shares0Common StockSEC:0001209191-21-043535:0
625 shares0Class A Common StockSEC:0001209191-21-040697
625 shares0Class A Common StockSEC:0001209191-21-040697:0
100,000 shares0Common StockSEC:0001209191-21-031839
100,000 shares0Common StockSEC:0001209191-21-031839:0
17 of 17 declarations
About SULIMAN SHEHNAAZ
Shehnaaz Suliman is the CEO, Chairman of the Board, and Board Member at Alector, Inc., 10x Genomics, Inc., and Ultragenyx Pharmaceutical Inc. She is responsible for the strategic direction of these companies, ensuring alignment of operations with overall objectives. Her leadership and vision are essential in guiding these organizations through a competitive landscape.
